Loading…
GSK announced it will invest $30 billion in the United States over the next five years, including a new factory in Pennsylvania for cancer drugs. The investment is expected to create thousands of jobs.
GSK announced a $139 million investment to expand its biopharmaceutical manufacturing site in Rockville, MD, to increase bulk drug substance production for BENLYSTA by close to 50%.
| Site | Largest | Latest |
|---|---|---|
| Pennsylvania, United States | $30.0B | 2025-09-17 |
| Rockville, United States | $139.0M | 2017-05-05 |